Arovella Therapeutics Limited (AU:ALA) has released an update.
Arovella Therapeutics Limited has announced the application for quotation of 400,000 new ordinary fully paid securities on the ASX under the code ALA, with the securities being issued on June 17, 2024. The company has complied with the requirements set out in Appendix 2A of the ASX Listing Rules.
For further insights into AU:ALA stock, check out TipRanks’ Stock Analysis page.
